Scientists at Johns Hopkins Medicine say they used a form of magnetic imaging to track cell therapy injections commonly used to treat certain autoimmune diseases and cancers.

A novel PET radiotracer can accurately detect deep vein thrombosis in the legs and reveal whether clots have migrated to the lungs. By enabling whole‑body imaging of blood clots in a single scan, the approach may support faster and more efficient diagnosis -- particularly for patients who also require evaluation for potentially life‑threatening pulmonary embolism. This research was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 Annual Meeting, and the collection of images showcasing the visualization of blood clots in the legs and in the lungs, has been selected as the 2026 SNMMI Henry N. Wagner, Jr., Image of the Year.

Martin G. Pomper, MD, PhD, known for his pioneering work in molecular imaging and the development of prostate-specific membrane antigen (PSMA) targeted agents, was awarded the Benedict Cassen Prize during the Society of Nuclear Medicine and Molecular Imaging 2026 Annual Meeting. The honor is awarded every two years by the Education and Research Foundation (ERF) for Nuclear Medicine and Molecular Imaging in recognition of outstanding achievement and work leading to a major advance in nuclear medicine science.

A University of Utah team of engineers and mathematicians developed and tested technology to support a smartwatch that can accurately monitor blood pressure continuously by tracking the electrical properties of blood flow at the wrist. No cuff or no calibration are required for this device that could revolutionize how a critical health metric is monitored, providing doctors with much more useful information about patients’ cardiovascular health.